What if you could get the rapid antidepressant benefits of ketamine without the dissociative side effects? A team at Weill Cornell Medicine has done just that by reverse engineering ketamine's mechanism of action and replicating its effects using a combination of three existing, safer drugs.
The Research
Led by Dr. Conor Liston and Dr. Joshua Levitz, the scientists published two complementary studies in Cell (April 23, 2026) and Science Advances. First, they pinpointed that ketamine targets a specific subset of opioid receptors on interneurons in the prefrontal cortex. These interneurons normally act as brakes on brain activity, but chronic stress makes them hyperactive, suppressing mood-regulating circuits. By briefly activating these opioid receptors, ketamine silences the interneurons for just 15–20 minutes, reawakening the prefrontal cortex. Second, they discovered that long-term relief requires a “handshake” between two receptors—TrkB and mGluR5—triggered by the protein BDNF. This interaction strengthens weakened synaptic connections and prevents them from being weakened again.
The team then demonstrated they could achieve the same cortical reawakening by combining low doses of three existing drugs (a mu-opioid receptor agonist, a delta-opioid receptor agonist, and a KOR antagonist), avoiding the high doses that cause dissociation and blood pressure spikes. Because all three drugs are already FDA-approved for other uses, a clinical trial is launching immediately.
Why It Matters
About one-third of depression patients don't respond to first-line treatments, and another third have treatment-resistant depression. Ketamine offers rapid relief for some, but its side effects limit its use. This research suggests that a targeted, low-dose combination could provide the same rapid antidepressant effect without the “trip” or addiction risk. For anyone interested in cognitive well-being, this work illustrates how understanding brain mechanisms can lead to safer interventions that restore prefrontal cortex function—a region critical for emotion regulation and decision-making.
What You Can Do
While these treatments are not yet available, you can support your prefrontal cortex health by engaging in regular aerobic exercise, which boosts BDNF—the same protein that strengthens synaptic connections in the study. Aim for 30 minutes of moderate activity most days. Additionally, practice mindfulness meditation to reduce stress, which can help prevent hyperactivity of brain circuits similar to those targeted by the new approach.
Source: Neuroscience News
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.
